medigraphic.com
Colegio de Medicina Interna de México.

2024, Number 8

<< Back Next >>

Med Int Mex 2024; 40 (8)

Yamaguchi syndrome

González PC, Lean SAM, Chavira MC, González REA, Hernández CPF

Language: Spanish
References: 14
Page: 547-551
PDF size: 251.76 Kb.


ABSTRACT

Background: Yamaguchi syndrome, first described in 1979, is an apical hypertrophic cardiomyopathy, which represents 1-2% of hypertrophic cardiomyopathies with a high incidence in Japan; however, there are not population studies regarding its incidence among Latin-American patients.
Clinical case: A 41-year-old male patient, who presented with chest pain, ruling out acute coronary syndrome; the electrocardiogram evidenced giant inverted T waves in the precordial leads. Magnetic resonance image established the diagnosis of predominantly apical hypertrophic cardiomyopathy.
Conclusions: Despite being a very rare disease in Mexico, it is essential to consider Yamaguchi syndrome a possible differential diagnosis in the approach of chest pain.


REFERENCES

  1. Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, et al. Longtermoutcome in patients with apical hypertrophic cardiomyopathy.JACC 2002; 39 (4): 638–645. DOI: 10.1016/s0735-1097(01)01778-8

  2. Reddy M, Thatai D, Bernal J, Pradhan J, Afonso L. Apicalhypertrophic cardiomyopathy: Potential utility of Strainimaging. Eur J Echocardiogr 2008; 9 (4): 560-562. DOI:10.1016/j.euje.2007.02.004

  3. Yamaguchi H, Ishimura T, Nishiyama S, et al. Hypertrophicnonobstructive cardiomyopathy with giant negative Twaves (apical hypertrophy): ventriculographic and echocardiographicfeatures in 30 patients. Am J Cardiol 1979; 44 (3): 401-412. DOI: 10.1016/0002-9149(79)90388-6

  4. Yusuf SW, Bathina JD, Banchs J, Mouhayar EN, Daher IN.Apical hypertrophic cardiomyopathy. World J Cardiol 2011;3 (7): 256-259. doi: 10.4330/wjc.v3.i7.256

  5. Calzadilla-Gutiérrez H-R, Orihuela Á, Flores-Choque C-A,et al. Síndrome de Yamaguchi: hallazgo de la valoraciónpreoperatoria. A propósito de un caso. Rev Arg Med 2019;7 (4): 256-259.

  6. Gómez NB, Herrera-Escandón A, Negrete-Salcedo A,Quiñones-Calvache C. Miocardiopatía hipertrófica apical:Síndrome de Yamaguchi. Acta Médica Colombiana 2021;46 (4). https://doi.org/10.36104/amc.2021.2082

  7. Shah FA, Fujikawa P, Miller JB, Singh H. A novel case ofYamaguchi syndrome in a Hispanic male. Cureus 2021; 13(9): e17651. doi: 10.7759/cureus.17651

  8. Hughes RK, Knott KD, Malcolmson J, et al.: Apical hypertrophiccardiomyopathy: the variant less known. J Am HeartAssoc 2020; 3 (7): 256-259. doi: 10.4330/wjc.v3.i7.256

  9. Villa SC, Martínez-Losas P, Ceña JS, Majado BT, et al.Malignant pericardial effusion as a presentation of AIDS:The role of flow cytometry in early diagnosis. Rev EspCardiol (English ed.) 2018; 71 (9): 764-765. DOI: 10.1016/j.rec.2017.05.034

  10. Elliot P, Anastasakis A, Borger M, Borggrefe M, et al. Guíade práctica clínica de la ESC 2014 sobre el diagnóstico ymanejo de la miocardiopatía hipertrófica. Rev Esp Cardiol2015; 68 (1): 63. e1-e52.

  11. Gruner C, Care M, Siminovitch K, Moravsky G, et al. Sarcomereprotein gene mutations in patients with apicalhypertrophic cardiomyopathy. Circulación: Genética cardiovascular2011; 4 (3): 288-295. https://doi.org/10.1161/CIRCGENETICS.110.958835

  12. Mirabbasi SA, Khalighi K, Mukkamala S, Kodali A. A rare caseof apical hypertrophic cardiomyopathy (AHCM). J CommunHosp Int Med Perspect 2017; 7 (2) :122-125. https://doi.org/10.1080/20009666.2 017.1324238

  13. Payus AO, Sholeh FM, Mustafa N. Yamaguchi syndrome- a pseudoacute coronary syndrome of the young: a casereport on apical hypertrophic cardiomyopathy. J Med Sci2019; 39: 197-9. DOI: 10.4103/jmedsci.jmedsci_179_18

  14. Jan MF, Todaro MC, Oreto L, Tajik AJ. Apical hypertrophiccardiomyopathy: present status. Int J Cardiol 2016; 222:745-759. DOI: 10.1016/j.ijcard.2016.07.154




2020     |     www.medigraphic.com